Study suggests spices outperform chemo and radiation for treating cancer

( Natural News ) Turmeric is an ancient spice commonly used in Indian cuisine. Aside from giving curries extra flavor and color, this humble yellow-orange root is rapidly becoming a new health wonder. It has been used for thousands of years in Ayurvedic and Chinese medicine, but in the past few decades word of its powerful medicinal benefits has reached the Western world as well. In fact, turmeric now tops the list as one of the most frequently researched medicinal herbs. Its therapeutic use has been proven to be safe and effective in the treatment of various conditions and with no adverse side effects. Curcumin, turmeric’s active compound, gives the spice its bright yellow color and is responsible for most of its health-promoting effects. Multiple studies found evidence of curcumin’s potential to treat or prevent a host of human diseases, including obesity, diabetes, cardiovascular diseases, neurological issues, cancer, and other chronic, inflammatory diseases. According to Green Med Info , turmeric’s ability to prevent and treat medical conditions has been linked to over 800 different diseases. Now, one of the deadliest forms of brain cancer, glioblastoma, can be added to that list. Glioblastoma is an aggressive, fast-growing form of brain cancer which is usually treated with chemotherapy, surgery, and radiation. These overpriced conventional treatments, however, have shown little to no effect in keeping cancer away. In contrary, they may be making it worse. Turmeric beats traditional treatments for lethal brain cancer In some patients, cancer has the ability to develop resistance to conventional therapies through the production of radioresistant and chemoresistant cancer stem cells. Knowing that glioblastoma tumors are packed with glioma stem cells, it is no surprise these treatments have shown little success. The power of the elements : Discover Colloidal Silver Mouthwash with quality, natural ingredients like Sangre […]

Click here to view full article